Skip to main content
Caplight Logo









Brinter

Brinter

Private
Winston-Salem, North CarolinaHealthcare & Life Scienceshttps://brinter.com/

Last Round

Series A

Jun 30, 2026

Total Funding Raised

$3.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Brinter is a biotechnology company that develops 3D bioprinting solutions and regenerative implants for the life sciences and orthopedic industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, 3D Printing, Biotech Equipment, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

3D bioprintingbioprintertissue engineeringbio-inksdrug discoveryregenerative medicinebiomanufacturingdrug delivery systemslab automationbiotech equipmentorgan-on-a-chiptissue modelsbiotech hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Brinter Comparables

Compare Brinter with similar companies based on industry and business-model similarity.

Brinter comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Poietis
88%
Regemat 3D
86%
RegenHU
84%

Brinter Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 30, 2026
GrantDec 11, 2024
AcceleratorJun 6, 2024
AcceleratorMar 11, 2024
Pre SeedFeb 16, 2023
Seed
Jun 10, 2021

Key People

Founding team and executive leadership

Theo Arhio

Chief Operating Officer

Executive Team

Brinter Investors

Notable investors and investment history

Brinter investors
InvestorRounds
InnovestorSeed
TechstarsAccelerator
RegenMed EngineGrant
AthensmedPre Seed, Seed
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 346% MoM, reaching 1.1K.

  • Jun 30, 2026

    Completed Series A funding round.

Brinter Filings

Explore SEC and related filing metadata, where available.

Brinter filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Brinter's valuation, stock price, and market status.

Is Brinter a public or private company?

Brinter is a private company.

What is the current stock price of Brinter?

Brinter is a private company with no public stock price. No recent secondary market data is available.

How much is Brinter worth (valuation)?

Valuation information for Brinter is not publicly available.

Can I buy Brinter stock?

Brinter shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Brinter's last funding round?

Brinter's most recent funding round was Grant on December 11, 2024.

Who are the main investors in Brinter?

Key investors in Brinter include Innovestor, Techstars, National Science Foundation.

Will Brinter IPO soon?

No public IPO plans have been announced for Brinter.

How can I track Brinter secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Brinter's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWinston-Salem, North Carolina
Employee Range9
Year Founded2020
Last FundingJun 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?